Saskatoon Luncheon: Two Perspectives on the Role of Biosimilar Drugs

Saskatoon Luncheon: Two Perspectives on the Role of Biosimilar Drugs

February 15, 2017 11:30 AM to 1:15 PMRadisson Hotel, Saskatoon, Saskatchewan
Area of Interest: Benefits, Networking Format: In Person

Join us for lunch at the Radisson Hotel Saskatoon for a joint presentation that will discuss two perspectives on biosimilar drugs:

  • Richard York, Associate Director of Private Drug Plans at Merck Canada Inc., will discuss perspectives on the role of biosimilar drugs in addressing healthcare sustainability; how biosimilar drugs are different from generic drugs, and global and Canadian perspectives on biosimilar drugs.
  • Durhane Wong-Rieger, President and Chief Executive Officer of the Canadian Organization for Rare Disorders, will discuss the findings from a survey with 300 Canadian patients about their perspectives on biosimilars, including safety, availability, use, monitoring, and support issues. She will also provide an overview of discussions with patients representing various diseases that indicate some of the factors that influence acceptance and confidence.

  

     

Richard York is Associate Director of Private Drug Plans at Merck Canada Inc.

In his 25 years at Merck, Richard has served in a variety of key commercial and policy positions. Twelve of those years have been dedicated to working in the public and private drug reimbursement environment. Other roles have included Sales Management, Marketing, and Government Relations.

In his current position, Richard works across Merck’s diverse array of medicines and vaccines in key therapeutic areas as Diabetes, Hepatitis C, Respiratory Disease, Cancer, and Infectious Diseases.

Richard is very familiar with the complex challenges facing plan sponsors and drug benefit providers today in their efforts to ensure that drug benefit programs remain affordable, sustainable, and of high quality to plan members.


Durhane Wong-Rieger is President and Chief Executive Officer of the Canadian Organization for Rare Disorders (the umbrella organization of patients and patient groups) and chair of the Consumer Advocare Network, a national network for patient engagement in healthcare policy and advocacy. She is also President and Chief Executive Officer of the Institute for Optimizing Health Outcomes (providing training and direct service on health coaching and patient self-management). Internationally, Wong-Rieger is past-chair of the International Alliance of Patient Organizations, board member of Rare Disease International, member of Health Technology Assessment International Patient/Citizen Involvement Interest Group and member of the editorial board of The Patient-Patient Centred Outcomes Research. She is a certified health coach and licensed T-Trainer with the Stanford-based Living a Healthy Life with Chronic Conditions. Wong-Rieger has served on numerous health policy advisory committees and panels and is a member of the Patient Liaison Forum for the Canadian Drugs and Technologies in Health.

Wong-Rieger has a PhD in psychology from McGill University and was professor at the University of Windsor, Canada from 1984-1999, She is married and has two children. She is a trainer, a frequent lecturer, and an author of three books and many articles.



Schedule   Registration: 11:30 am, Lunch: 11:45 am, Presentation:  12:15 pm – 1:15 pm    

Location  Radisson Hotel Saskatoon, 405 20th St E, Saskatoon, SK 

CE Credit This session qualifies for 1 Continuing Education credit for the Insurance Council of Saskatchewan (one credit per hour). 

THANK-YOU TO OUR 2016-17 PROGRAM SPONSORS!

Saskatchewan Blue Cross

Sun Life Financial

Chubb

iA Financial Group

Triasima

Great-West Life

Aon Hewitt

Mercer

Fees and Registration
Membership TypesRegular Price
Member$38.09 CDN
Plan Sponsor Individual Member$38.09 CDN
Associate Member$38.09 CDN
Student Membership$23.81 CDN
Non Member$57.14 CDN
Cancellation Policy
By continuing to use this website, you are agreeing to our use of cookies.